Salix Pharmaceuticals, Ltd. news

   Watch this stock
Showing stories 1 - 10 of about 87   

Articles published

SLXP 172.81
price chart
Salix Pharmaceuticals Ltd: Here's Why Valeant Fought So Hard To Acquire Salix
It's already been an expensive week for Valeant Pharmaceuticals International Inc. The company announced Monday that it added roughly a billion dollars to its original bid to acquire Salix Pharmaceuticals Ltd. The new offer came after Endo ...
Endo International plc May Hunt Smaller Targets After Losing Salix ...  Bidness ETC
Why Salix Pharmaceuticals Ltd. Stock Was Throttled
What: Salix Pharmaceuticals (NASDAQ:SLXP), a biopharmaceutical company focused on developing and acquiring drugs targeting gastrointestinal diseases, gave its own shareholders indigestion today when the stock plunged as much as 40% on ...
Salix Pharmaceuticals profit, revenue miss estimates  Reuters
Salix Pharmaceuticals Reports 3Q2014 Results  Business Wire (press release)
Related articles »  
Why Salix Pharmaceuticals, Ltd. Stock Was Clobbered in November
What: Shares of Salix Pharmaceuticals (NASDAQ:SLXP), a biopharmaceutical company that develops and acquires drugs designed to treat gastrointestinal diseases, was clobbered in November and fell by 29%, based on data from S&P Capital IQ, after the ...
Related articles »  
Salix Pharmaceuticals CEO Plans to Retire
Salix Pharmaceuticals Ltd. said President and Chief Executive Carolyn Logan plans to retire by the end of January, months after an accounting issue may have derailed the drug maker's takeover.
Salix Pharmaceuticals, Ltd CEO Plans To Retire  Bidness ETC
Carolyn Logan to Retire as Chief Executive Officer of Salix Pharmaceuticals  Business Wire (press release)
Related articles »  
Salix Pharmaceuticals Reports 4Q2014 and FY2014 Results
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products and medical devices for the prevention and treatment of gastrointestinal diseases.
Salix Pharmaceuticals, Ltd. (SLXP) Q4 Revenue Hits A Record Low  Bidness ETC
An Overview of Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) Fourth Quarterly ...  Stocks.org
SEC investigating former Salix Pharma execs, Reuters reports
Federal regulators opened an investigation into former executives from Salix Pharmaceuticals to determine if they misled investors relating to inventory disclosures in 2014, according to Reuters, which cited a “person familiar with the probe.
Endo makes takeover offer for Salix Pharmaceuticals
Endo International PLC has made a takeover bid for Salix Pharmaceuticals Ltd., seeking to upend Valeant Pharmaceuticals International Inc.'s roughly $10 billion agreement to buy the drug maker.
Endo International plc - Ordinary Shares Tries To Woo Salix Pharmaceuticals ...  Bidness ETC
Surprise Rival Bid Emerges for Salix  Wall Street Journal
Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix ...
LAVAL, Quebec, April 1, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced the expiration of the tender offer (the "Offer") by a subsidiary of Valeant Pharmaceuticals International ...
Valeant Pharma (VRX) Announces Results of $173/Share Salix Pharma (SLXP) Tender  StreetInsider.com
Valeant closes $11B deal for Raleigh's Salix Pharmaceuticals  Triangle Business Journal
Valeant To Acquire Salix Pharmaceuticals For $158.00 Per Share In Cash
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock ...
Salix Pharmaceuticals, Ltd. Rises On Valeant Buyout Rumor  ValueWalk
Valeant Pharmaceuticals Intl Inc Cuts To The Chase; Announces Salix ...  Bidness ETC
Salix Pharmaceuticals, Ltd. (SLXP) Q1 Earnings Preview: What To Expect
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) is scheduled to announce its financial results for the first quarter of fiscal year 2015 (1QFY15) on Thursday, May 7 after the markets close.